You might also like
Clinical Case Study Compendium:
PDF case reports 1 & 2
The impact of gilteritinib in daily practice as salvage treatment and as bridging therapy. Real-World Experiences by Dr. A. de Voeght...
View more
Clinical Case Study Compendium:
Video case report 5
Real-World Experiences by prof. dr. M. Beckers, UZ Leuven. Video of case report 5
View more
The Role of Gilteritinib in the Treatment of Relapsed or Refractory FLT3-Mutated AML¹
Video
Video of case report 1:
In this interview Dr. A. de Voeght (Sart Tilman-CHU Liège, Belgium), discusses his experiences with gilteritinib as a salvage intervention therapy post venetoclax-azacitidine.
Intended for: practitioners hematology
Why: up-to-date knowledge TKI2 related target therapy
When: watch now
Duration: 4 minutes
1: Acute Myeloid Leukemia; 2: Tyrosine Kinase Inhibitor.
MAT-BE-XOS-2026-00003 FEB 2026
AML: Acute Myeloid Leukemia
COPYRIGHT © 2026 ASTELLAS PHARMA B.V. MAT-BE-XOS-2025-00030 - DEC 2025